| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000250295.2 |
Axitinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042486463 |
Resistant |
| ENSG00000250295.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04682593 |
Sensitive |
| ENSG00000250295.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.037770823 |
Sensitive |
